MKS Instruments, Inc. (NASDAQ:MKSI)‘s stock had its “buy” rating reaffirmed by stock analysts at Stifel Nicolaus in a note issued to investors on Tuesday, October 24th, MarketBeat Ratings reports. They currently have a $108.00 price target on the scientific and technical instruments company’s stock, up from their previous price target of $98.00. Stifel Nicolaus’ target price would suggest a potential upside of 3.70% from the company’s current price.
Several other brokerages also recently weighed in on MKSI. Deutsche Bank AG began coverage on MKS Instruments in a report on Wednesday, July 5th. They set a “buy” rating and a $84.00 price target for the company. BidaskClub downgraded MKS Instruments from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 5th. Finally, KeyCorp reaffirmed an “outperform” rating and set a $100.00 price objective on shares of MKS Instruments in a research report on Saturday, September 16th. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. MKS Instruments currently has a consensus rating of “Buy” and an average price target of $109.75.
Shares of MKS Instruments (NASDAQ:MKSI) opened at $104.15 on Tuesday. MKS Instruments has a one year low of $49.95 and a one year high of $110.60. The company has a debt-to-equity ratio of 0.29, a current ratio of 4.23 and a quick ratio of 3.10. The firm has a market cap of $5,654.82, a price-to-earnings ratio of 19.69, a PEG ratio of 1.13 and a beta of 1.11.
MKS Instruments (NASDAQ:MKSI) last posted its quarterly earnings results on Tuesday, October 24th. The scientific and technical instruments company reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.10. The business had revenue of $486.27 million during the quarter, compared to the consensus estimate of $476.24 million. MKS Instruments had a net margin of 16.97% and a return on equity of 21.21%. MKS Instruments’s revenue was up 27.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.88 EPS. analysts expect that MKS Instruments will post 5.89 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This report was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another site, it was stolen and reposted in violation of international copyright & trademark law. The original version of this report can be read at https://www.dispatchtribunal.com/2017/11/12/mks-instruments-mksi-buy-rating-reiterated-at-stifel-nicolaus.html.
In related news, CFO Seth H. Bagshaw sold 7,500 shares of the business’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $85.80, for a total transaction of $643,500.00. Following the completion of the transaction, the chief financial officer now owns 21,615 shares in the company, valued at approximately $1,854,567. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Brian Charles Quirk sold 2,000 shares of the business’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $107.90, for a total value of $215,800.00. Following the transaction, the vice president now owns 13,785 shares of the company’s stock, valued at approximately $1,487,401.50. The disclosure for this sale can be found here. In the last ninety days, insiders sold 10,100 shares of company stock worth $909,085. Corporate insiders own 1.65% of the company’s stock.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Riverhead Capital Management LLC raised its position in shares of MKS Instruments by 71.9% in the 2nd quarter. Riverhead Capital Management LLC now owns 2,063 shares of the scientific and technical instruments company’s stock worth $139,000 after acquiring an additional 863 shares in the last quarter. Bridgeworth LLC acquired a new position in MKS Instruments during the 3rd quarter valued at about $203,000. Greenwood Capital Associates LLC acquired a new position in MKS Instruments during the 3rd quarter valued at about $204,000. Creative Planning increased its position in MKS Instruments by 22.8% during the 2nd quarter. Creative Planning now owns 2,239 shares of the scientific and technical instruments company’s stock valued at $151,000 after buying an additional 416 shares in the last quarter. Finally, CAPROCK Group Inc. acquired a new position in MKS Instruments during the 3rd quarter valued at about $213,000. 96.01% of the stock is owned by hedge funds and other institutional investors.
MKS Instruments Company Profile
MKS Instruments, Inc is a global provider of instruments, subsystems and process control solutions that measures, controls, powers, delivers, monitors and analyzes critical parameters of advanced manufacturing processes. The Company operates through two segments, including the Vacuum & Analysis segment and the Light & Motion segment.
Receive News & Ratings for MKS Instruments Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments Inc. and related companies with MarketBeat.com's FREE daily email newsletter.